Erkki I Ruoslahti

Rancho Santa Fe, CA, United States of America

Erkki I Ruoslahti

Average Co-Inventor Count = 2.3

ph-index = 26

Forward Citations = 2,565(Granted Patents)

Forward Citations (Not Self Cited) = 2,284(Sep 21, 2024)

DiyaCoin DiyaCoin 7.55 

Inventors with similar research interests:


Location History:

  • Rancho Sante Fe, CA (US) (1992 - 1999)
  • Olivenhain, CA (US) (1983 - 2001)
  • Ranco Santa Fe, CA (US) (2007)
  • San Diego, CA (US) (1997 - 2011)
  • San Francisdo, CA (US) (2013)
  • Bueuton, CA (US) (2013)
  • Busilton, CA (US) (2015)
  • Buelton, CA (US) (2016)
  • Buellton, CA (US) (2009 - 2022)
  • Rancho Santa Fe, CA (US) (1991 - 2024)
  • La Jolla, CA (US) (2010 - 2024)


Years Active: 1983-2025

where 'Filed Patents' based on already Granted Patents

132 patents (USPTO):

Title: The Innovative Mind of Erkki I Ruoslahti

Introduction: Erkki I Ruoslahti, a distinguished inventor based in Rancho Santa Fe, CA (US), is renowned for his groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Erkki I Ruoslahti holds several patents in the areas of targeted drug delivery systems, cell adhesion molecules, and tumor microenvironment modulation, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning several decades, Erkki I Ruoslahti has made significant strides in the development of novel therapies for cancer treatment, particularly focusing on utilizing nanotechnology for precise drug delivery to tumor cells.

Collaborations: Throughout his career, Erkki I Ruoslahti has collaborated with leading research institutions, pharmaceutical companies, and biotechnology firms to further advance his pioneering research in the field of molecular medicine.

Conclusion: Erkki I Ruoslahti's relentless pursuit of innovation and his profound impact on the field of biotechnology and medical research solidify his position as a visionary inventor whose work continues to shape the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…